Literature DB >> 24120911

Impaired bile acid handling and aggravated liver injury in mice expressing a hepatocyte-specific RXRα variant lacking the DNA-binding domain.

Astrid Kosters1, Julio C Felix2, Moreshwar S Desai3, Saul J Karpen4.   

Abstract

BACKGROUND & AIMS: Retinoid X Receptor α (RXRα) is the principal heterodimerization partner of class II Nuclear Receptors (NRs), and a major regulator of gene expression of numerous hepatic processes, including bile acid (BA) homeostasis through multiple partners. Specific contributions of hepatic RXRα domains in heterodimer function in response to either BA load or ductular cholestasis are not fully characterized.
METHODS: Wild-type (WT) mice and mice expressing a hepatocyte-specific RXRα lacking the DNA-Binding-Domain (hs-RxrαΔex4(-/-)), which retains partial ability to heterodimerize with its partners, were fed a 1% cholic acid (CA) diet for 5 days, a 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) diet for 3 weeks, or control diet.
RESULTS: Serum ALT (6.5-fold; p<0.05), AST (9.3-fold; p=0.06) and BA (2.8-fold; p<0.05) were increased in CA-fed hs-RxαΔex4(-/-) mice compared to CA-fed WT mice, but were equally induced between genotypes by DDC-feeding. CA-feeding elevated total (4.4-fold; p=0.06) and unconjugated (2.2-fold; p<0.02) bilirubin levels in hs-RxrαΔex4(-/-) mice compared to WT mice, but not in DDC-fed hs-RxrαΔex4(-/-) mice. Increased necrosis and inflammation was observed in CA-fed, but not in DDC-fed hs-RxrαΔex4(-/-) mice. Apoptotic markers DR5, CK8, CK18 RNA were increased in CA- and DDC-fed hs-RxrαΔex4(-/-) mice. Cleaved caspase 3, CK18 and p-JNK protein were elevated in CA-fed but not in DDC-fed hs-RxrαΔex4(-/-) mice. Induction of Ostβ and Cyp2b10 RNA was impaired in CA-fed and DDC-fed hs-RxrαΔex4(-/-) mice. Surprisingly, DDC-fed hs-RxrαΔex4(-/-) mice showed attenuated fibrosis compared to DDC-fed WT mice.
CONCLUSIONS: These two models of cholestasis identify common and injury-specific roles for RXRα heterodimers and the functional relevance of an intact RXRα-DBD in the hepatocytic adaptive cholestatic response.
Copyright © 2013 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Apoptosis; BA; Bile acids; Biliary fibrosis; CA; DBD; DDC; DNA-Binding Domain; Liver injury; NR; Nuclear Receptors; Nuclear receptors; RXRα; Retinoid X Receptor α; Retinoid x receptor; bile acids; cholic acid

Mesh:

Substances:

Year:  2013        PMID: 24120911      PMCID: PMC3946967          DOI: 10.1016/j.jhep.2013.09.026

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  34 in total

1.  Bile acid-induced Mallory body formation in drug-primed mouse liver.

Authors:  Peter Fickert; Michael Trauner; Andrea Fuchsbichler; Conny Stumptner; Kurt Zatloukal; Helmut Denk
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

2.  The role of hepatocyte RXR alpha in xenobiotic-sensing nuclear receptor-mediated pathways.

Authors:  Yan Cai; Tamiko Konishi; Guang Han; Khozema H Campwala; Samuel W French; Yu-Jui Yvonne Wan
Journal:  Eur J Pharm Sci       Date:  2002-02       Impact factor: 4.384

3.  Hepatocyte-specific mutation establishes retinoid X receptor alpha as a heterodimeric integrator of multiple physiological processes in the liver.

Authors:  Y J Wan; D An; Y Cai; J J Repa; T Hung-Po Chen; M Flores; C Postic; M A Magnuson; J Chen; K R Chien; S French; D J Mangelsdorf; H M Sucov
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

4.  Cholestasis increases tumor necrosis factor-related apoptotis-inducing ligand (TRAIL)-R2/DR5 expression and sensitizes the liver to TRAIL-mediated cytotoxicity.

Authors:  Hajime Higuchi; Steven F Bronk; Makiko Taniai; Ali Canbay; Gregory J Gores
Journal:  J Pharmacol Exp Ther       Date:  2002-11       Impact factor: 4.030

5.  Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450.

Authors:  E G Schuetz; S Strom; K Yasuda; V Lecureur; M Assem; C Brimer; J Lamba; R B Kim; V Ramachandran; B J Komoroski; R Venkataramanan; H Cai; C J Sinal; F J Gonzalez; J D Schuetz
Journal:  J Biol Chem       Date:  2001-08-16       Impact factor: 5.157

6.  Cytokeratins as targets for bile acid-induced toxicity.

Authors:  Peter Fickert; Michael Trauner; Andrea Fuchsbichler; Conny Stumptner; Kurt Zatloukal; Helmut Denk
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

7.  PPARbeta regulates vitamin A metabolism-related gene expression in hepatic stellate cells undergoing activation.

Authors:  Karine Hellemans; Krista Rombouts; Erik Quartier; Andrea S Dittié; Andreas Knorr; Liliane Michalik; Vera Rogiers; Frans Schuit; Walter Wahli; Andrea Geerts
Journal:  J Lipid Res       Date:  2002-11-16       Impact factor: 5.922

8.  Bile acids up-regulate death receptor 5/TRAIL-receptor 2 expression via a c-Jun N-terminal kinase-dependent pathway involving Sp1.

Authors:  Hajime Higuchi; Annette Grambihler; Ali Canbay; Steven F Bronk; Gregory J Gores
Journal:  J Biol Chem       Date:  2003-10-14       Impact factor: 5.157

9.  Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity.

Authors:  Grace L Guo; Gilles Lambert; Masahiko Negishi; Jerrold M Ward; H Bryan Brewer; Steven A Kliewer; Frank J Gonzalez; Christopher J Sinal
Journal:  J Biol Chem       Date:  2003-08-15       Impact factor: 5.157

Review 10.  Evolving therapies for liver fibrosis.

Authors:  Detlef Schuppan; Yong Ook Kim
Journal:  J Clin Invest       Date:  2013-05-01       Impact factor: 14.808

View more
  7 in total

1.  Inflammation-associated upregulation of the sulfated steroid transporter Slc10a6 in mouse liver and macrophage cell lines.

Authors:  Astrid Kosters; Demesew F Abebe; Julio C Felix; Paul A Dawson; Saul J Karpen
Journal:  Hepatol Res       Date:  2015-11-19       Impact factor: 4.288

2.  Farnesoid X receptor-induced lysine-specific histone demethylase reduces hepatic bile acid levels and protects the liver against bile acid toxicity.

Authors:  Young-Chae Kim; Sungsoon Fang; Sangwon Byun; Sunmi Seok; Byron Kemper; Jongsook Kim Kemper
Journal:  Hepatology       Date:  2015-02-27       Impact factor: 17.425

3.  Resveratrol effectively attenuates α-naphthyl-isothiocyanate-induced acute cholestasis and liver injury through choleretic and anti-inflammatory mechanisms.

Authors:  Tao Wang; Zhi-xing Zhou; Li-xin Sun; Xia Li; Zhi-meng Xu; Mi Chen; Guo-lin Zhao; Zhen-zhou Jiang; Lu-yong Zhang
Journal:  Acta Pharmacol Sin       Date:  2014-11-24       Impact factor: 6.150

4.  Simultaneous bile duct and portal vein ligation induces faster atrophy/hypertrophy complex than portal vein ligation: role of bile acids.

Authors:  Weizheng Ren; Geng Chen; Xiaofeng Wang; Aiqun Zhang; Chonghui Li; Wenping Lv; Ke Pan; Jia-Hong Dong
Journal:  Sci Rep       Date:  2015-02-13       Impact factor: 4.379

5.  Critical role of RanBP2-mediated SUMOylation of Small Heterodimer Partner in maintaining bile acid homeostasis.

Authors:  Dong-Hyun Kim; Sanghoon Kwon; Sangwon Byun; Zhen Xiao; Sean Park; Shwu-Yuan Wu; Cheng-Ming Chiang; Byron Kemper; Jongsook Kim Kemper
Journal:  Nat Commun       Date:  2016-07-14       Impact factor: 14.919

6.  BRD4 inhibition and FXR activation, individually beneficial in cholestasis, are antagonistic in combination.

Authors:  Hyunkyung Jung; Jinjing Chen; Xiangming Hu; Hao Sun; Shwu-Yuan Wu; Cheng-Ming Chiang; Byron Kemper; Lin-Feng Chen; Jongsook Kim Kemper
Journal:  JCI Insight       Date:  2020-12-08

7.  Maternal obesogenic diet enhances cholestatic liver disease in offspring.

Authors:  Michael D Thompson; Holly Hinrichs; Austin Faerber; Phillip I Tarr; Nicholas O Davidson
Journal:  J Lipid Res       Date:  2022-03-25       Impact factor: 6.676

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.